Evidence map›Paper›PMID 25247579›Full record

ReviewInternational journal of molecular sciences2014

Brain metastases in gastrointestinal cancers: is there a role for surgery?

Johannes Lemke, Jan Scheele, Thomas Kapapa, Silvia von Karstedt, Christian Rainer Wirtz, Doris Henne-Bruns, Marko Kornmann

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Incidence and predictors of brain metastasis in colorectal cancer patients.International journal of colorectal disease · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Johannes LemkeClinic of General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. johanneslemke@gmx.de.
Jan ScheeleClinic of General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. jan.scheele@uniklinik-ulm.de.
Thomas KapapaClinic of Neurosurgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. thomas.kapapa@uniklinik-ulm.de.
Silvia von KarstedtUCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6DD, UK. s.karstedt@ucl.ac.uk.
Christian Rainer WirtzClinic of Neurosurgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. rainer.wirtz@uniklinik-ulm.de.
Doris Henne-BrunsClinic of General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. doris.henne-bruns@uniklinik-ulm.de.
Marko KornmannClinic of General and Visceral Surgery, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89071, Germany. marko.kornmann@uniklinik-ulm.de.
University Hospital Ulm · DEUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About 10% of all cancer patients will develop brain metastases during advanced disease progression. Interestingly, the vast majority of brain metastases occur in only three types of cancer: Melanoma, lung and breast cancer. In this review, we focus on summarizing the prognosis and impact of surgical resection of brain metastases originating from gastrointestinal cancers such as esophageal, gastric, pancreatic and colorectal cancer. The incidence of brain metastases is <1% in pancreatic and gastric cancer and <4% in esophageal and colorectal cancer. Overall, prognosis of these patients is very poor with a median survival in the range of only months. Interestingly, a substantial number of patients who had received surgical resection of brain metastases showed prolonged survival. However, it should be taken into account that all these studies were not randomized and it is likely that patients selected for surgical treatment presented with other important prognostic factors such as solitary brain metastases and exclusion of extra-cranial disease. Nevertheless, other reports have demonstrated long-term survival of patients upon resection of brain metastases originating from gastrointestinal cancers. Thus, it appears to be justified to consider aggressive surgical approaches for these patients.

Indexed as

Neurosurgical ProceduresBrain NeoplasmsCarcinomaCraniotomyDisease-Free SurvivalEsophageal NeoplasmsGastrointestinal NeoplasmsHumansIncidencePalliative CarePancreatic NeoplasmsPatient SelectionPrognosisQuality of LifeTreatment Outcome

Identifiers

PMID25247579
PMCPMC4200819
OpenAlexW2123781822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.